What does Kidswell Bio Corporation do?
Kidswell Bio Corporation develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan. Its pipeline products include GBS-001 and GBS-010 for oncology; GBS-007 for ophthalmic disease; and GBS-011 for renal disease. The company also offers GCT-103 that is…
What is Kidswell Bio Corporation's P/E and P/B ratio?
Kidswell Bio Corporation has a P/E ratio of -18.9 and a P/B ratio of 4.03.
What is Kidswell Bio Corporation's debt-to-equity ratio?
Kidswell Bio Corporation has a debt-to-equity ratio of 1.35.
How much does Kidswell Bio Corporation owe compared with what it owns?
Kidswell Bio Corporation owes ¥0.70 for every ¥1 it owns (balance sheet Jun 2026), which is moderate.
What is Kidswell Bio Corporation's Positivity rank?
Kidswell Bio Corporation is ranked #8,368 of 10,750 companies globally and #3,409 of 3,683 in Japan on PositoAI, with a Positivity Score of 19,103.
Does Kidswell Bio Corporation have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Kidswell Bio Corporation.
Where can I read the latest news about Kidswell Bio Corporation?
Recent headlines about Kidswell Bio Corporation from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Kidswell Bio Corporation have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Kidswell Bio Corporation's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.